Correlation Between INmune Bio and Cassava Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Cassava Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Cassava Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Cassava Sciences, you can compare the effects of market volatilities on INmune Bio and Cassava Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Cassava Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Cassava Sciences.

Diversification Opportunities for INmune Bio and Cassava Sciences

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between INmune and Cassava is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Cassava Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cassava Sciences and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Cassava Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cassava Sciences has no effect on the direction of INmune Bio i.e., INmune Bio and Cassava Sciences go up and down completely randomly.

Pair Corralation between INmune Bio and Cassava Sciences

Given the investment horizon of 90 days INmune Bio is expected to generate 0.36 times more return on investment than Cassava Sciences. However, INmune Bio is 2.76 times less risky than Cassava Sciences. It trades about -0.02 of its potential returns per unit of risk. Cassava Sciences is currently generating about -0.13 per unit of risk. If you would invest  615.00  in INmune Bio on September 3, 2024 and sell it today you would lose (75.00) from holding INmune Bio or give up 12.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

INmune Bio  vs.  Cassava Sciences

 Performance 
       Timeline  
INmune Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Cassava Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cassava Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

INmune Bio and Cassava Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INmune Bio and Cassava Sciences

The main advantage of trading using opposite INmune Bio and Cassava Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Cassava Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cassava Sciences will offset losses from the drop in Cassava Sciences' long position.
The idea behind INmune Bio and Cassava Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities